Neuronetics Inc (STIM) financials

NASDAQ · Health Care

$2.25 -5.46% Close Oct 30, 2026 Live

Neuronetics revenue and earnings by year

Neuronetics's revenue was $149 million in the fiscal year to December 31, 2025, up 99.2% from the year before. Net income was -$39.0 million, -26.1% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 17.8% a year on average.

RevenueNet income
$0$100M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue149757165554963534034
Revenue growth99.2%5.0%9.4%17.9%12.3%-21.4%18.7%30.5%18.1%—
Gross profit72545250443847403128
Gross margin48.5%72.3%72.5%76.3%78.9%76.5%75.4%76.4%76.2%80.7%
Operating income-31-35-31-35-28-22-27-20-14-9
Operating margin-21.1%-46.2%-42.8%-53.8%-49.8%-45.3%-43.0%-37.6%-33.7%-27.3%
Net income-39-44-30-37-31-27-29-24-16-11
Net margin-26.1%-58.4%-42.3%-57.0%-56.4%-55.7%-46.4%-45.7%-39.7%-32.8%
Diluted EPS-$0.59-$1.38-$1.05-$1.38-$1.22-$1.46-$1.59———
Free cash flow-21-32-34-34-30-29-31-22-12-9

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open STIM in Markets.

How Neuronetics makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Greenbrook$26.9M64.7%
Neurostar$14.7M35.3%

See also: STIM returns

No forecast, no recommendation. This page describes Neuronetics Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.